Chondroitinase activity can be transduced by a lentiviral vector in vitro and in vivo

Journal of Neuroscience Methods

Volumn 199, Issue 2, 2011, Pages 208-213

  Jin, Ying ^a   Ketschek, Andrea ^a   Jiang, Zhilong ^a   Smith, George ^b   Fischer, Itzhak ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Axonal growth; Chondroitin sulfate proteoglycan; Chondroitinase; Gene therapy; Spinal cord injury

Indexed keywords

ANTIBODY; BACTERIAL ENZYME; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; N ACETYLGALACTOSAMINE 4 SULFATASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SUPERNATANT;

ANIMALS; AXONS; CELLS, CULTURED; CHICK EMBRYO; CHONDROITIN LYASES; FEMALE; GENETIC VECTORS; LENTIVIRUS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; TRANSDUCTION, GENETIC;

EID: 79960270392     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.05.007     Document Type: Article

References (30)

1. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., et al. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000, 20:2427-2438.
2. Baekelandt V., Eggermont K., Michiels M., Nuttin B., Debyser Z. Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Ther 2003, 10:1933-1940.
3. Bandtlow C.E., Zimmermann D.R. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000, 80:1267-1290.
4. Blesch A., Tuszynski M.H. Transient growth factor delivery sustains regenerated axons after spinal cord injury. J Neurosci 2007, 27:10535-10545.
5. Bonner J.F., Connors T.M., Silverman W.F., Kowalski D.P., Lemay M.A., Fischer I. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J Neurosci 2011, 31:4675-4686.
6. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2011, 84:306-316.
7. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
8. Curinga G.M., Snow D.M., Mashburn C., Kohler K., Thobaben R., Caggiano A.O., et al. Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J Neurochem 2007, 102:275-288.
9. Franz S., Weidner N., Blesch A. Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury. Exp Neurol 2011, January 31 [Epub ahead of print].
10. Han S.S., Kang D.Y., Mujtaba T., Rao M.S., Fischer I. Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol 2002, 177:360-375.
11. Han S.S., Liu Y., Tyler-Polsz C., Rao M.S., Fischer I. Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter. Glia 2004, 45:1-16.
12. Hendriks W.T., Eggers R., Carlstedt T.P., Zaldumbide A., Tannemaat M.R., Fallaux F.J., et al. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune " stealth" transgene. Restor Neurol Neurosci 2007, 25:585-599.
13. Hendriks W.T., Ruitenberg M.J., Blits B., Boer G.J., Verhaagen J. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 2004, 146:451-476.
14. Houle J.D., Tom V.J., Mayes D., Wagoner G., Phillips N., Silver J. Combining an autologous peripheral nervous system " bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 2006, 26:7405-7415.
15. Hunanyan A.S., Garcia-Alias G., Alessi V., Levine J.M., Fawcett J.W., Mendell L.M., et al. Role of chondroitin sulfate proteoglycans in axonal conduction in mammalian spinal cord. J Neurosci 2010, 30:7761-7769.
16. Hyatt A.J., Wang D., Kwok J.C., Fawcett J.W., Martin K.R. Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord. J Control Release 2010, 147:24-29.
17. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003, 182:399-411.
18. Jones L.L., Sajed D., Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 2003, 23:9276-9278.
19. Jones L.L., Tuszynski M.H. Chronic intrathecal infusions after spinal cord injury cause scarring and compression. Microsc Res Tech 2001, 54:317-324.
20. Lee H., McKeon R.J., Bellamkonda R.V. Sustained delivery of thermostabilized ChABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci USA 2010, 107:3340-3345.
21. Lepore A.C., Han S.S., Tyler-Polsz C.J., Cai J., Rao M.S., Fischer I. Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS. Neuron Glia Biol 2004, 1:113-126.
22. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995, 136:32-43.
23. Mitsui T., Shumsky J.S., Lepore A.C., Murray M., Fischer I. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J Neurosci 2005, 25:9624-9636.
24. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 2001, 4:465-466.
25. Pindzola R.R., Doller C., Silver J. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Dev Biol 1993, 156:34-48.
26. Properzi F., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem Soc Trans 2003, 31:335-336.
27. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
28. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
29. Tester N.J., Plaas A.H., Howland D.R. Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res 2007, 85:1110-1118.
30. Yick L.W., Cheung P.T., So K.F., Wu W. Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp Neurol 2003, 182:160-168.